Net Medical Xpress Solutions Inc
Change company Symbol lookup
Select an option...
NMXS Net Medical Xpress Solutions Inc
ARKG ARK Genomic Revolution ETF
BWA Borgwarner Inc
RCG RENN Global Entrepreneurs Fund, Inc.
SPI SPI Energy Co Ltd
CLH Clean Harbors Inc
CNLMF Collective Mining Ltd
ERIC Telefonaktiebolaget LM Ericsson
DVN Devon Energy Corp
HYZN Hyzon Motors Inc
Go

Health Care : Health Care Technology |
Company profile

Net Medical Xpress Solutions, Inc. provides a range of telemedicine services, including telemedicine software-as-a-service (SaaS), online diagnostic services, virtual specialist services, virtual primary care services and recruitment of telemedicine physicians. The Company operates through four segments: Net Medical Xpress Solutions, Net Medical Xpress Services, Net Medical Xpress Specialists and Net Medical Xpress Staffing. The Net Medical Xpress Solutions segment provides Picture Archiving and Communication System (PACs) hardware and software to hospitals and other medical facilities. The Net Medical Xpress Services provides medical diagnostic reading services. The Net Medical Xpress Specialists provides virtual specialist services to hospitals and other medical entities, and virtual primary care services to individual patients. The Net Medical Xpress Staffing specializes in the recruitment and staffing of physicians for telemedicine services.

Closing Price
$0.06
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,177
0

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in The Boston Beer Company, Inc., of Class Action Lawsuit and Upcoming Deadline - SAM

8:25 pm ET October 15, 2021 (PR Newswire) Print

Pomerantz LLP announces that a class action lawsuit has been filed against The Boston Beer Company, Inc. ("Boston Beer" or the "Company") (NYSE: SAM) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-08338, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Boston Beer securities between April 22, 2021 and September 8, 2021, inclusive (the "Class Period"). Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the "Exchange Act").

https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg

If you are a shareholder who purchased Boston Beer securities during the Class Period, you have until November 15, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here for information about joining the class action]

Boston Beer is a high-end alcoholic beverage company that produces hard seltzer, malt beverages (i.e. beers), and hard cider at its cidery and under contractual arrangements at other brewery locations.

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Boston Beer's hard seltzer sales were decelerating; (2) that, as a result, Boston Beer was reasonably likely to incur inventory write-offs; (3) that the Company was reasonably likely to incur shortfall fees payable to third party brewers; (4) that, as a result of the foregoing, Boston Beer's financial results would be adversely impacted; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On July 22, 2021, after the market closed, Boston Beer reduced its full year 2021 guidance, expecting earnings per share between $18 and $22, down from a prior range of $22 and $26. The Company cited softer-than-expected sales in the hard seltzer category and overall beer industry and also stated that it had "overestimated the growth of the hard seltzer category in the second quarter."

On this news, the Company's share price fell $246.54, or 26%, to close at $701.00 per share on July 23, 2021, on unusually heavy trading volume.

On September 8, 2021, after the market closed, Boston Beer withdrew its 2021 financial guidance, citing decelerating sales of hard seltzer products. The Company also stated that it "expects to incur hard seltzer-related inventory write-offs, shortfall fees payable to 3rd party brewers, and other costs" for the remainder of fiscal 2021.

On this news, the Company's share price fell $21.09, or 3.7%, to close at $538.31 per share on September 9, 2021, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com 888-476-6529 ext. 7980

https://c212.net/c/img/favicon.png?sn=DC41912&sd=2021-10-15

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert--pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-the-boston-beer-company-inc-of-class-action-lawsuit-and-upcoming-deadline--sam-301401622.html

SOURCE Pomerantz LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=DC41912&Transmission_Id=202110152025PR_NEWS_USPR_____DC41912&DateId=20211015

comtex tracking

COMTEX_395294037/1005/2021-10-15T20:25:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.